Vertex Pharmaceuticals Incorporated
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Sale
SILVA PAUL M officer: SVP & Chief Accounting..
 Common Stock 250 N/A N/A
Sale
SMITH IAN F officer: EVP, COO
 Common Stock 41,212 N/A N/A
Option
SMITH IAN F officer: EVP, COO
 Common Stock 41,212 N/A N/A
Option
SMITH IAN F officer: EVP, COO
 Stock Options 23,212 N/A N/A
Sale
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 1,118 N/A N/A
Sale
SMITH IAN F officer: EVP, COO
 Common Stock 2,850 N/A N/A
Option
BRANDT ERIC director
 Common Stock 27,500 N/A N/A
Sale
BRANDT ERIC director
 Common Stock 27,500 N/A N/A
Option
BRANDT ERIC director
 Stock Options 20,000 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Sale
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Stock Option 2,400 N/A N/A
Sale
LEWIS-HALL FREDA C officer: EVP, Medicines Develop..
 Common Stock 1,250 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Stock Option 2,400 N/A N/A
Sale
GARRISON RICHARD C officer: SVP and Catalyst
 Common Stock 1,975 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Sale
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Sale
LEWIS-HALL FREDA C officer: EVP, Medicines Develop..
 Common Stock 1,098 N/A N/A
Sale
LEWIS-HALL FREDA C officer: EVP, Medicines Develop..
 Common Stock 152 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 12,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 12,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 12,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Sale
GRAVES KURT officer: EVP, Chief Commercial..
 Common Stock 379 N/A N/A
Sale
SMITH IAN F officer: EVP, COO
 Common Stock 16 N/A N/A
Sale
SILVA PAUL M officer: SVP & Chief Accounting..
 Common Stock 218 N/A N/A
Sale
SACHDEV AMIT officer: EVP, Chief Patient Off..
 Common Stock 791 N/A N/A
Sale
GARRISON RICHARD C officer: SVP and Catalyst
 Common Stock 86 N/A N/A
Sale
BOGER KENNETH S officer: SVP & Chief Legal Offi..
 Common Stock 15,000 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Sale
MUELLER PETER officer: EVP, Global R&D, CSO
 Common Stock 2,400 N/A N/A
Option
MUELLER PETER officer: EVP, Global R&D, CSO
 Stock Option 2,400 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 26,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 13,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Stock Options 13,000 N/A N/A
Option
BOGER JOSHUA S director
 Common Stock 13,000 N/A N/A
Sale
BOGER JOSHUA S director
 Common Stock 5,600 N/A N/A
Sale
GRAVES KURT officer: EVP, Chief Commercial..
 Common Stock 485 N/A N/A

Showing 3200 to 3250 of 4198 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: